Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2026)

Camp4 Therapeutics has reported Cash from Investing Activities for 3 years, with the latest figure at $36000.0 in Q3 2025.

• Quarterly Cash from Investing Activities changed N/A year-over-year to $36000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $36000.0 (up 105.11% YoY) and the FY2025 annual result came in at -$243000.0, up 44.9% from the prior year.
• Cash from Investing Activities advanced to $36000.0 in Q3 2025 per CAMP's latest filing, from -$279000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $36000.0 in Q3 2025 and troughed at -$279000.0 in Q1 2025.
• A 3-year average of -$154500.0 and a median of -$203000.0 in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities declined 8.23% in 2024, then sank 1760.0% in 2025.
• Over 3 years, Cash from Investing Activities stood at -$243000.0 in 2023, then fell by 8.23% to -$263000.0 in 2024, then soared by 113.69% to $36000.0 in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $36000.0, -$279000.0, and -$263000.0 for Q3 2025, Q1 2025, and Q4 2024 respectively.